JPRN-jRCT2031230503进行中（未招募）3 期
A Phase 3, Randomized, Observer-Blind, Active-Controlled Study to Investigate the Immunogenicity of a Booster Dose of S-268023 compared with COMIRNATY (COVID-19)
Gomez Juan Carlos0 个研究点目标入组 600 人开始时间: 2023年12月11日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Participants aged 20 years or older, at the time of sigining the informed consent form.
- •-Participants who have passed 90 days or more after completing the primary vaccination or booster vaccination with an approved SARS-CoV-2 vaccine (excluding an approved monovalent XBB.1.5 SARS-CoV-2 vaccine).
- •-Participants with no infection history of SARS-CoV-2, or participants with infection history of SARS-CoV-2 who have not been infected since March 2023.
- •-Male and female.
排除标准
- •-Participants who have previously received an approved monovalent XBB.1.5 SARS-CoV-2 vaccines.
- •-Participants who tested positive SARS-CoV-2 infection (as determined by SARS-CoV-2 antigen test) at Screening.
研究者
相似试验
进行中（未招募）
3 期
A Phase 3 Study to Compare the Immunogenicity against COVID-19, of S-268019 to the ChAdOx1 nCoV-19 vaccine (COVID-19)JPRN-jRCT2051210151agata Tsutae1,000
进行中（未招募）
3 期
A Booster Study of S-268019 in Participants Aged 5 to 11 Years (COVID-19)Prevention of COVID-19JPRN-jRCT2031220530Gomez Juan Carlos100
进行中（未招募）
1 期
A Phase 3 Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and OlderInfluenzaEUCTR2022-001638-12-PLModernaTX, Inc.23,000
进行中（未招募）
1 期
A Phase 3 Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and OlderMedDRA version: 20.0Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsInfluenzaEUCTR2022-001638-12-DEModernaTX, Inc.23,000
进行中（未招募）
1 期
A Phase 3 Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and OlderMedDRA version: 20.0Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsInfluenzaEUCTR2022-001638-12-DKModernaTX, Inc.23,000